Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally-Qualified Health Centers: A Thematic Qualitative Analysis

Sarah E Philbin,Lacey P Gleason,Stephen Persell,Eve Walter,Lucia C. Petito,Anjan Tibrewala,Clyde W Yancy,Rinad S Beidas,Jane E Wilcox,R Kannan Mutharasan,Donald M Lloyd-Jones,Matthew J O'Brien,Abel N Kho,Megan C McHugh,Justin D Smith,Faraz S Ahmad

DOI: https://doi.org/10.1101/2024.10.28.24316301

2024-10-29

Abstract:Background: Clinical guidelines recommend medications from four drug classes, collectively referred to as quadruple therapy, to improve outcomes for patients with heart failure with reduced ejection fraction (HFrEF). Wide gaps in uptake of these therapies persist across a range of settings. In this qualitative study, we identified determinants (i.e., barriers and facilitators of quadruple therapy intensification, defined as prescribing a new class or increasing the dose of a currently prescribed medication. Methods: We conducted interviews with physicians, nurse practitioners, physician assistants, and pharmacists working in primary care or cardiology settings in an integrated health system or Federally Qualified Health Centers (FQHCs). We report results with a conceptual model integrating two frameworks: 1) the Theory of Planned Behavior (TPB), which explains how personal attitudes, perception of attitudes of others, and perceived behavioral control influence intentions and behaviors; and 2) The Consolidated Framework for Implementation Research (CFIR) 2.0 to understand how multi-level factors influence attitudes toward and intention to use quadruple therapy. Results: Thirty-one clinicians, including thirteen eighteen (58%) primary care and (42%) cardiology clinicians, participated in the interviews. Eight (26%) participants were from FQHCs. A common facilitator in both settings was the belief in the importance of quadruple therapy. Common barriers included challenges presented by patient frailty, clinical inertia, and time constraints. In FQHCs, primary care comfort and ownership enhanced the intensification of quadruple therapy while limited access to and communication with cardiology specialists presented a barrier. Results are presented using a combined TPB-CFIR framework to help illustrate the potential impact of contextual factors on individual-level behaviors. Conclusions: Determinants of quadruple therapy intensification vary by clinician specialty and care setting. Future research should explore implementation strategies that address these determinants by specialty and setting to promote health equity.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the factors influencing the intensification of guideline - directed medical therapy (GDMT) for heart failure in integrated health systems and federally qualified health centers (FQHCs). Specifically, the study aims to identify and analyze the barriers and facilitators encountered by physicians and other healthcare providers when prescribing or adjusting the quadruple therapy for heart failure (including four drug classes) in these different settings.

### Research Background

Heart failure is a disease with high morbidity and mortality, affecting more than 6.5 million adults in the United States and disproportionately affecting the economically disadvantaged population. For approximately 40% of heart failure patients, especially those with heart failure with reduced ejection fraction (HFrEF), clinical guidelines recommend combination therapy from four drug classes, the so - called quadruple therapy. These drugs can significantly improve the quality of life, reduce the risk of hospitalization and mortality, but in practice, the utilization rate of these therapies is far below the ideal level.

### Research Objectives

This study explored the determinants of healthcare providers in different specialties (primary care and cardiology) and different medical settings (large - scale integrated health systems and FQHCs) when prescribing quadruple therapy through qualitative methods. The study specifically focused on the following two aspects:

1. **Barriers**: such as patient vulnerability, clinical inertia, time constraints, etc.
2. **Facilitators**: such as the belief in the importance of quadruple therapy, the comfort and sense of responsibility of primary care physicians, etc.

### Research Methods

The research team collected the views of healthcare providers such as physicians, nurses, and pharmacists from integrated health systems and FQHCs through semi - structured interviews. The interview content was analyzed around two theoretical frameworks: the Theory of Planned Behavior (TPB) and the Consolidated Framework for Implementation Research (CFIR 2.0). These two frameworks respectively explain how personal attitudes, social norms, and the sense of behavioral control affect behavioral intentions, and how multi - level factors affect attitudes and usage intentions towards quadruple therapy.

### Main Findings

- **Common facilitators**: All respondents generally believed that quadruple therapy was very important for heart failure patients.
- **Common barriers**: including patient vulnerability, clinical inertia, time constraints, etc.
- **Barriers specific to FQHCs**: limited access to and communication channels with specialists, as well as patients' socioeconomic factors (such as housing insecurity, multiple chronic diseases, etc.).
- **Facilitators specific to FQHCs**: Primary care physicians have a stronger sense of comfort and responsibility in managing quadruple therapy.

### Conclusions

The determinants of quadruple therapy intensification vary depending on the specialty and working environment of healthcare providers. Future research should explore specific implementation strategies for different specialties and environments to promote health equity and improve the treatment outcomes of heart failure patients.